Cholecalciferol is vitamin D3, which helps your body absorb calcium to keep bones strong and healthy. It's used to treat vitamin D deficiency and conditions like osteoporosis and low calcium levels.[2] Deltavit is currently approved and in use across 108 indications[4].[1]
Deltavit is one of 1991 small molecule programs targeting Insulin resistance. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
2828 competitors in Breast Cancer
Deltavit
Tecentriq
DATROWAY
Cymbalta
Blenoxane
Zinecard
Recentin
Chantix
Avastin
Zoladex
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details